首页> 外文期刊>Molecular cancer therapeutics >Anticancer effects of tanshinone I in human non-small cell lung cancer.
【24h】

Anticancer effects of tanshinone I in human non-small cell lung cancer.

机译:丹参酮I在人非小细胞肺癌中的抗癌作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Tanshinones are the major bioactive compounds of Salvia miltiorrhiza Bunge (Danshen) roots, which are used in many therapeutic remedies in Chinese traditional medicine. We investigated the anticancer effects of tanshinones on the highly invasive human lung adenocarcinoma cell line, CL1-5. Tanshinone I significantly inhibited migration, invasion, and gelatinase activity in macrophage-conditioned medium-stimulated CL1-5 cells in vitro and also reduced the tumorigenesis and metastasis in CL1-5-bearing severe combined immunodeficient mice. Unlike tanshinone IIA, which induces cell apoptosis, tanshinone I did not have direct cytotoxicity. Real-time quantitative PCR, luciferase reporter assay, and electrophoretic mobility shift assay revealed that tanshinone I reduces the transcriptional activity of interleukin-8, the angiogenic factor involved in cancer metastasis, by attenuating the DNA-binding activity of activator protein-1 and nuclear factor-kappaB in conditioned medium-stimulated CL1-5 cells. Microarray and pathway analysis of tumor-related genes identified the differentially expressed genes responding to tanshinone I, which may be associated with the Ras-mitogen-activated protein kinase and Rac1 signaling pathways. These results suggest that tanshinone I exhibits anticancer effects both in vitro and in vivo and that these effects are mediated at least partly through the interleukin-8, Ras-mitogen-activated protein kinase, and Rac1 signaling pathways. Although tanshinone I has a remarkable anticancer action, its potential anticoagulant effect should be noted and evaluated.
机译:丹参酮是丹参根的主要生物活性化合物,在中药的许多治疗方法中都使用丹参酮。我们研究了丹参酮对高侵袭性人肺腺癌细胞系CL1-5的抗癌作用。丹参酮I显着抑制体外巨噬细胞条件培养基刺激的CL1-5细胞的迁移,侵袭和明胶酶活性,还减少了携带CL1-5的重度联合免疫缺陷小鼠的肿瘤发生和转移。丹参酮IIA不同于诱导细胞凋亡的丹参酮IIA,它没有直接的细胞毒性。实时定量PCR,萤光素酶报告基因测定和电泳迁移率变动测定表明,丹参酮I通过减弱激活剂蛋白1和核糖核酸的DNA结合活性来降低白介素8的转录活性,白介素8是参与癌症转移的血管生成因子。条件培养基刺激的CL1-5细胞中的因子-κB。肿瘤相关基因的微阵列和途径分析鉴定了对丹参酮I应答的差异表达基因,其可能与Ras促分裂原激活的蛋白激酶和Rac1信号通路相关。这些结果表明丹参酮I在体外和体内均表现出抗癌作用,并且这些作用至少部分是通过白介素8,Ras促丝裂原激活的蛋白激酶和Rac1信号传导途径介导的。尽管丹参酮I具有显着的抗癌作用,但应注意并评估其潜在的抗凝作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号